Metabolic and nutritional Flashcards
What is a porphyrin?
- Tetrapyrrole and is aromatic
- It incorporates iron to create haem, and undergoes the haem biosynthesis pathway to get there
- When there is an issue with one of the enzymes, then there is accumulation in the substrates
- Porphyrins get excited by the Soret Band which is 408 nm
Overarching Porphyria pathophysiology
- The Soret band excites the molecule into an excited singlet state
- The singlet state results in:
- Hydroxy radical production which directly damages tissue
- Complement production, which you see on IF
- Mast cell degranulation
- MMP activity
- Particular to certain subtypes:
- EPP: PPP is lipophilic so it hands out in the endothelial cells, so the pathology is mainly in the upper dermal blood vessels so you get pain from sun exposure
- PCT: UPP is more water soluble, so it diffuses to surrounding tissue –> this causes lysis of the cells in the superficial dermis, resulting in a blister under the basal lamina (coalescing of vacuoles)
- VP: this has both CPP and PPP but for some reason the hydrophilic component predominates more
- There is no correlation between porphyrin concentration and association with cutaneous disease
Porphyria histology
- In the dermis, eosinophilic hyaline is deposited in and around the vessel walls - its pink, and is PAS positive and diastase resistant. There is lots in EPP
- In bullous lesions: sub-epidermal bullae which is cell poor, and the dermal papilla prottrudes into the blister cavity called festooning or caterpillar
- IF –> IG at DEJ
- Electron microscopy: reduplication of vascular basal lamina
- Particular:
- EPP: vessel wall changes are more pronounced, deposition can be extensive and look like colloid milium
- PCT: basement membrane zone changes predominate here
Porphyria Photoprotection principles
- The Soret wavelength light is at 408 nm so they need broad spectrum protection
- They basically need long shirts, hats, etc
- Sunscreens: physical blockers (titanium, zinc, iron) but these aren’t enough
- Dihydroxyacetone paint –> induces formation of light-absorbing brown pigment in the stratum corneum
- Clear window films can absorb UV light –> car, home windows
- If requiring surgery, for certain types, filters over lights in theatre
Acute attacks of porphyria + triggers
- This occurs with HP, AIP and VP (HAV), and is most common in AIP
- It is triggered when something induces CYP450 –> this exacerbates the inability of the liver pathway to respond adequately because of PGB deaminase deficiency
- Triggers:
- Drugs –> metabolised by CYP450
- Hormones –> menstrual cycle (affects women:men 5:1)
- Recreational –> alcohol, cannabis
- Stress, infection, fasting
Clinical features of acute attacks of porphyria
- Gastrointestinal: abdominal pain, vomiting, constipation
- Metabolic: hyponatraemia
- Neurological: convulsions, acute autonomic neuropathy, motor neuropath
- Respiratory: paralysis
- Psych: abnormal behaviour, confusion, generalised anxiety
Diagnosis and treatment of acute attacks of porphyria
- Increased urinary PBG, and the higher it is the more likely the acute attack Treatment - admit - fluid management - Haem arginate
Congenital erythropoietic porphyria AKA Gunther Disease clinical
- Deficiency of UP cosynthetase
- Autosomal recessive
Clinical - wide spectrum
- In utero: hydrops fatalis
- At birth:
- Brown amniotic fluid
- Blistering on light –> photherapy can be triggering
- Secondary infections
- Scarring, erosion of terminal phalanges, onycholysis, destructive change, pseudosclerodermatous
- Hypertrichosis
- Hypo + hyperpigmentation
- Later onset as adult - associated with haematological –> BM myelodysplasia
- Extracutaneous:
- Haem - haemolytic anaemia
- Bones and teeth
- Eyes
- Earlier life expectancy ~40 years
Gunther disease investigations
Investigations –> elevated everywhere
- Tissue: accumulation of UP and CP
- Red cell and urine: large amount of UP and CP
- Faeces: increased CP
Gunther management
- Photoprotection
- Prevention of secondary infection
- Haem:
- hypertransfusion
- complicated by iron overload
- Allogenic BM transplant
- difficult, need to find HLA-compatible donor
- hypertransfusion
- Prognosis:
- reduced life span (40 years)
- Genetic counselling:
- chance of sibling having 25%
- can detect in utero via amniotic fluid or chorionic villous biopsy
PCT types
- Deficiency of UROD
Types - 1: 75% of population, sporadic mutation, enzyme deficiency is in the liver only
- 2: 25%, familial, autosomal dominant with low penetration, in all tissues of the body
- 3: rare, hereditary enzyme deficiency localised to the liver
PCT pathophysiology
- accumulated uroporphyrin (hydrophilic) diffuses from plasma into surrounding tissues
- causes phototoxic reaction in the upper dermis of the skin –> cell lysis in the superficial dermis, formation of membrane limited vacuoles which merge to produce a blister
Risk factors for PCT
- Haemachromatosis
- Infectious: HCV, HIV, HAV, HBV
- Alcohol
- Oestrogens: OCP, HRT, tamoxifen
- Less common:
- haemodialysis
- NIDDM, SLE, dermatomyositis
- Haem: malignancy, sideroblastic anaemia, thalassaemia
PCT Clinical
- Blistering, skin fragility, bullae, atrophic scars, milia, hyper and hypopigmentation
- Type 1 - arises in middle aged people
- Other cutaneous features: scarring alopecia, hypertrichosis, hyperpigmentation, morphoea-like plaques (possible induction of collagen synthesis by uroporphyrin)
- Nails: photo-distributed onycholysis
- Variants:
- Homozygous form of familial is HEP –> 90% reduction in UROD. This is severe, with photosensitivity at birth, blisters, mutilating scarring, hypertrichosis, shortened phalanges, milder haemolysis than CEP. Life expectancy is normal.
Liver implications of PCT
- Accumulated porphyrins are carcinogenic to the liver
- Liver biopsy: stainable iron, fatty change, intracellular porphyrin crystals
- 15% develop cirrhosis
- 3% develop hepatocellular carcinoma
- Risk factors for carcinoma are:
- symptomatic >10 years
- severe changes on histology
- HCV
- Male
- > 50 yrs
- requires monitoring of liver via USS and alpha-fetal protein
PCT investigations
- Remember - it is a liver disorder with secondary effects on the skin
- Urine: positive, particularly UP
- Faeces: positive, particularly isocoproporphyrin
- Histology:
1. Subepidermal bullae with sparse inflammatory infiltrate
2. Festooning of the dermal papillae in the bullae: the papillae protrude up
3. Thickened uppder dermal capillary walls: this is due to deposition of fibrillar glycoprotein, is PAS positive and diastase negative
4. May have caterpillar bodies in the blister roof: linear, eosinophilic PAS positive globules composed of basement membrane material and degenerating keratinocytes - Liver biopsy is warranted
Management of PCT
- Prevention
- Photoprotection
- Eliminate risk factors
- Genetic counselling: difficult to justify screening as no acute attacks
- Physical methods
- Venesection
- ~500 mL every 1-2 weeks
- takes blistering 2-3 months to resolve, and skin fragility 6-9 months
- relapse 2.5 years later
- Excision and graft of sclerodermoid lesions
- Venesection
- Medical
- Hydroxychloroquine
- Low dose 100 mg twice weekly
- promotes uroporphyrin excretion in bile
- Desferrioxamine
- Chelates hepatic ion, requires S/C pump at night
- Expensive
- Erythropoieitin
- Treatment of choice in renal failure
- Hydroxychloroquine
EPP definition
Ferrochelatase deficiency - final enzyme of the pathway. It hurts rather than blisters.
Epidemiology
- super rare
- some have been associated with haem malignancy
EPP clinical
- Baby:
- usually only physical sign is oedema, with severe attacks they can have purpuric lesions, crusted erosions and vesicles
- immediate pain to bright light –> crying in pram, worse in spring and summer
- pain, tingling, discomfort, itching
- partial relief with cold water and wet clothes
- Older:
- Signs: thickening over MCP and IP joints, vermicular scarring on nose, shallow linear/punctate/circular scars on cheeks, forehead, radial scars around lips, skin roughened and pebbly
- 50% still have no physical signs
- Psychosocial ++
- May improve with pregnancy due to anaemia
- Variant: associated with palmar keratoderma
- Liver:
- PPP can precipitate and form gallstones in ~ 12% patients
- PPP is also hepatotoxic –> 1% severe liver damage, some may require liver transplant but can still get disease back in graft
EPP investigations
- Red cell-free protoporphyrin is increase which is diagnostic. This makes sense as its vascular
- Faecal: increased protoporphyrin in 60%
- Urinary: normal
- Biopsy:
- endothelial damage in superficial dermal vessels in acute phase
- chronic phase: deposition of hyaline material (PAS positive) in walls of blood vessels of upper dermal and papillary vascular plexuses –> can be so extensive looks like coloid milia
- IF: IgG
EPP management
- Prevention:
- Photoprotection
- Monitoring - LFTs and red cell PPP checked annually
- Genetic counselling: autosomal dominant with incomplete penetrance, probability of offspring acquiring and suffering is under 10%, testing for partner is now available
- Acute attacks
- analgesia
- severe –> admission
- Medical therapy:
- Oral beta-carotene
- believed to scavenge free radicals involved in the acute phototoxic reaction
- can cause reversible skin pigmentation
- PUVA
- may be useful in that it induces epidermal thickening and pigmentation
- Afamelanotide
- alpha-melanocytic stimulating hormone analogue –> has shown promising results
- Oral beta-carotene
- Physical:
- Allogenic bone marrow transplant
- Liver transplant in liver issues
Hereditary coproporphyria
- Autosomal dominant inherited deficiency of CPP oxidase
- puberty onwards
- 10-2% have cutaneous fragility and blistering, however it is mostly non-cutaneous
- Investigations: increased UPP and CPP in urine and CPP in faeces
Variegate porphyria epi
- Really common in South Africa –> 1/20, much less in Europe and elsewhere
- at least 80% of south africans carry a pathogenic mutation of VP but are asymptomatic
Variegate pathophysiology
- Autosomal dominant inherited deficiency of PPP oxidase
- Accumulated CPP and PPP inhibit PBG –> resulting in acute attacks
Varigate porphyria clinical
- Cutaneous
- 70% have cutaneous involvement
- adolescence/young adulthood onset
- indistinguishable from PCT: skin fragility, tense blistering in photo-distributed sites, pigment changes, scarring, scleroderma, milia, hypertrichosis
- Nail: occasionally photo-onycholysis
- No seasonal variation
- Acute photosensitivity when hepatic injury (due to increased porphyrins I guess)
- Extracutaneous
- Intercurrent biliary obstruction –> exacerbated cutaneous diease
- Increased lifetime risk of hepatocellular carcinoma
- Acute attacks –> occurs more in women, declined in recent times due to prophylactic measures
- Sometimes goes into clinical and biochemical remission in old age
- Variants:
- homozygous VP mutation –> clinically much worse, occurs in neonates and have significant neurological issues –> epilepsy, delayed development, nystagmus, hand deformities
VP diagnosis
Plasma spectrofluorimetry peak: 626 nm –> this is diagnostic in the absence of a raised free red cell porphyrin
VP Management
- Prevention
- Photoprotection
- Avoid medications and low calorie diets and alcohol
- Emergency identification bracelet
- Genetic counselling:
- identify relatives - negative test is uninformative but positive means they have it
- Risk of passing to offspring is 50%, 20% of those will have symptoms
- Medications
- Beta-carotene and canthaxanthin? limited protection
- Physical
- Liver transplant for acute attacks
Pseudoporphyria
- Not actually porphyria, and is clinically and histologically indistinguishable from PCT
- Cause:
- Photosensitising drugs - FIND
- Frusemide
- Isotretinoin
- NSAIDS - naproxen, nabumetone
- Dapsone, doxycycline (other tetracyclines)
- Haemodialysis
- Sunbeds
- Photosensitising drugs - FIND
- Clinically indistinguishable from PCT, however less likely to see hyperpigmentation, hypertrichosis and sclerodermoid changes
- DDx: PCT, EPP, bullous dermatoses
- Ix: normal porphyrins, histo identical to PCT
- Management: key is to remove provoking factor and photoprotection
How do you diagnose and treat vit A deficiency
Serum retinol <20
Rx: 50 000-200 000 iu daily
How do you diagnose and treat pellagra
24 hour urinary niacin + clinical
Rx: nicotinamide 500 mg a day for 3-4 weeks - neuropsych improves within 24-48 hrs
Medications that can decrease zinc absorption
Diuretics
Penicillamine
Valproate
Zinc mutation for acrodermatitis enteropathica
SLC39A4
Investigations to do for zinc deficiency
Albumin - when it’s low can contribute
ALP is a zinc dependent enzyme
Low zinc <70 fasting or <65 non fasting
Histo: psoriasiform hyperplasia
Zinc deficiency treatment
Acquired: 0.5-1 mg/kg/day for kids, 15-30 mg daily for adults
AE 3 mg/kg/day forever